Published in Gene Therapy Weekly, April 13th, 2006
According to a study from Japan, "Activation of the activator protein 1 (AP-1) plays a critical role in oncogenesis by human T-cell leukemia virus type 1 (HTLV-1), the etiologic agent of ATL, and is required for maintenance of the malignant phenotype. Curcumin (diferuloylmethane), the major pigment of the spice turmeric, has anti-tumor activity; however, the effect of curcumin against ATL has not been elucidated."
"In this study, we examined the effects of curcumin on AP-1 activity in HTLV-1-infected T-cell lines," explained M. Tomita and colleagues, University of Ryukyus. "Curcumin suppressed...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.